We are live on
!
Find out more
SAM
Sabadell Asset Management Portfolio holdings
AUM
$482M
1-Year Est. Return
27.83%
This Fund
S&P 500
1 Year Est. Return
+27.83%
AUM
$470M
AUM Growth
-$11.5M
(-2.4%)
Holding
121
Top Buys
| 1 | +$11.6M | |
| 2 | +$8.68M | |
| 3 | +$8.47M | |
| 4 |
American Electric Power
AEP
|
+$7.14M |
| 5 |
Boston Scientific
BSX
|
+$5.17M |
Top Sells
| 1 | +$7.19M | |
| 2 | +$6.76M | |
| 3 | +$6.41M | |
| 4 |
Freeport-McMoran
FCX
|
+$6.08M |
| 5 |
Gilead Sciences
GILD
|
+$5.55M |
Sector Composition
| 1 | Technology | 26.83% |
| 2 | Communication Services | 17.52% |
| 3 | Healthcare | 13.06% |
| 4 | Financials | 11.2% |
| 5 | Consumer Discretionary | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Union Pacific
UNP
$153B
| $1.12M | 0.24% |
5,785
+2,105
|
|
||
77
Johnson & Johnson
JNJ
$550B
| $1.11M | 0.24% |
6,685
+746
|
|
||
78
CSX Corp
CSX
$84.8B
| $1.1M | 0.23% |
37,693
+4,020
|
|
||
79
Procter & Gamble
PG
$350B
| $1.09M | 0.23% |
7,183
|
|
||
80
Amgen
AMGN
$182B
| $1.08M | 0.23% |
4,256
+1,459
|
|
||
81
Nike
NKE
$66.9B
| $1.07M | 0.23% |
8,869
-746
|
|
||
82
Infosys
INFY
$42.8B
| $1.07M | 0.23% |
61,666
-35,163
|
|
||
83
Qualcomm
QCOM
$238B
| $1.07M | 0.23% |
8,669
|
|
||
84
JD.com
JD
$37.2B
| $1.05M | 0.22% |
26,017
|
|
||
85
ICICI Bank
IBN
$100B
| $1.04M | 0.22% |
48,162
-4,047
|
|
||
86
Accenture
ACN
$78.6B
| $1.01M | 0.21% |
3,574
|
|
||
87
Truist Financial
TFC
$60.2B
| $972K | 0.21% |
30,369
+8,023
|
|
||
88
Texas Instruments
TXN
$294B
| $964K | 0.21% |
5,441
|
|
||
89
Prudential Financial
PRU
$37B
| $884K | 0.19% |
10,673
|
|
||
90
New Oriental
EDU
$7.16B
| $853K | 0.18% |
22,533
-3,049
|
|
||
91
HDFC Bank
HDB
$129B
| $827K | 0.18% |
24,334
|
|
||
92
Becton Dickinson
BDX
$39.7B
| $700K | 0.15% |
2,780
|
|
||
93
MakeMyTrip
MMYT
$4.43B
| $483K | 0.1% |
20,611
|
|
||
94
Itaú Unibanco
ITUB
$85.9B
| $476K | 0.1% |
111,775
|
|
||
95
Baxter International
BAX
$10.3B
| $409K | 0.09% |
9,684
|
|
||
96
Allstate
ALL
$56.9B
| $356K | 0.08% |
+3,100
|
|
||
97
Thermo Fisher Scientific
TMO
$173B
| $283K | 0.06% |
488
|
|
||
98
Stellantis
STLA
$18.4B
| $241K | 0.05% |
13,720
-98,071
|
|
||
99
UBS Group
UBS
$167B
| $222K | 0.05% |
10,697
-126,134
|
|
||
100
Moderna
MRNA
$25.4B
| $219K | 0.05% |
1,416
|
|